Factors associated with aGVHD in multivariate analysis
Variable . | Relative risk (95% CI) . | P . |
---|---|---|
Patient sex | ||
Male | 1.00 | |
Female | 1.64 (1.12-2.41) | .010 |
Patient age | ||
42 y or less | 1.00 | |
More than 42 y | 1.70 (1.55-2.51) | .007 |
CD34+ cells, × 106/kg | ||
(1) 2 or less | 1.00 | P = .021 |
(2) More than 2 to 4 | 2.02 (0.98-4.20) | P12 = .058 |
(3) More than 4 | 2.62 (1.30-5.28) | P13 = .007 |
CD3+ cells, × 106/kg | ||
(1) 0.05 or less | 1.00 | P = .022 |
(2) More than 0.05 to 0.1 | 2.06 (1.01-4.18) | P12 = .045 |
(3) More than 0.1 | 2.45 (1.29-4.62) | P13 = .006 |
Variable . | Relative risk (95% CI) . | P . |
---|---|---|
Patient sex | ||
Male | 1.00 | |
Female | 1.64 (1.12-2.41) | .010 |
Patient age | ||
42 y or less | 1.00 | |
More than 42 y | 1.70 (1.55-2.51) | .007 |
CD34+ cells, × 106/kg | ||
(1) 2 or less | 1.00 | P = .021 |
(2) More than 2 to 4 | 2.02 (0.98-4.20) | P12 = .058 |
(3) More than 4 | 2.62 (1.30-5.28) | P13 = .007 |
CD3+ cells, × 106/kg | ||
(1) 0.05 or less | 1.00 | P = .022 |
(2) More than 0.05 to 0.1 | 2.06 (1.01-4.18) | P12 = .045 |
(3) More than 0.1 | 2.45 (1.29-4.62) | P13 = .006 |
indicates 2 degrees of freedom;P12, probability of testing (1) = (2); andP13, probability of testing (1) = (3).